Dose Cancer Research Results
Dose, Dosage: Click to Expand ⟱
| Source: |
| Type: |
Drug dosage vs efficacy, and actual dosage number of research papers.
|
Park, Parkinson's Disease (PD): Click to Expand ⟱
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, and is due to the degeneration of dopaminergic neurons. It is multifactorial, caused by genetic and environmental factors and currently has no definitive cure.
-CoQ10 deficiency was observed at a higher frequency in Parkinson's disease
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
- |
Review, |
Arthritis, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
cardioP↑, Inflam↓, cognitive↑, *hepatoP↑, *ROS?, *SOD↑, *GSH↑, *MMP↑, *GutMicro↑, ChemoSen↑, *TNF-α↓, *IL10↑, *IL6↓, *eff↑, *ROS↓, *COX2↓, *NF-kB↓, *STAT3↓, *PGE2↓, *MPO↓, *IL1β↓, *MMP2↓, *MMP9↓, *β-Amyloid↓, *neuroP↑, *Dose↝, *BioAv↝, *BioAv↝, *BBB↑, *BDNF↑,
| - |
in-vivo, |
AD, |
NA |
|
|
|
- |
in-vivo, |
Park, |
NA |
|
|
|
*neuroP↑, *toxicity∅, *AChE↓, *ROS↓, *antiOx↑, *lipid-P↓, *cognitive↑, *memory↑, *Dose↝, *BioAv↓, *TumCCA↑, *BBB↝,
| - |
Review, |
Arthritis, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*other↝, *other↝, *CRP↓, *eff↝, *other↑, *CXCR4↓, *IL1β↓, *IL6↓, *IL17↓, *IL18↓, *TNF-α↓, *MMP9↓, *PGE2↓, *COX1↓, *COX2↓, *PI3K↓, *Akt↓, *other↑, TumCCA↑, Apoptosis↑, ROS↑, JNK↑, TumAuto↑, Hif1a↓, BNIP3↝, HSP90↓, Fas↑, FasL↑, ETC↓, VEGF↓, angioG↓, RadioS↑, *neuroP↑, *HSP70/HSPA5↑, *ROS↓, *MMP↑, *Cyt‑c↓, *Casp3↓, *Casp9↓, *MAPK↓, *Dose⇅, *HSPs↑, BioAv↓, Dose↝,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*AntiAge↑, *cardioP↑, *Inflam↓, *antiOx↑, *lipid-P↓, *QoL↑, *neuroP↑, *Dose↝, *BP↓, *IGF-1↑, *IGFBP1↑, *eff↑, *LDL↓, *HDL↑, *eff↑, *other↑, *RenoP↑, *ROS↓, *TNF-α↓, *IL6↓, *other↝, *other∅,
| - |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*eff↑, *BBB↑, *Dose↝, *neuroP↑, *cognitive↑, *toxicity∅,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
NA, |
AD, |
NA |
|
|
|
- |
NA, |
Diabetic, |
NA |
|
|
|
- |
NA, |
Stroke, |
NA |
|
|
|
- |
NA, |
LiverDam, |
NA |
|
|
|
- |
NA, |
Park, |
NA |
|
|
|
*mtDam↓, *BioAv↝, *BioAv↑, *OS↑, *eff↑, *eff↑, *cognitive↑, *DNAdam↓, *SIRT1↑, *cardioP↑, *ROS↓, *Dose↝, *BioAv↑, *hepatoP↑, *eff↑, *BG↓, *creat↓,
| - |
Study, |
AD, |
NA |
|
|
|
- |
Study, |
Park, |
NA |
|
|
|
*Risk↑, *Dose↝, *Dose↓, *other↝,
Showing Research Papers: 1 to 7 of 7
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 7
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
ETC↓, 1,
Cell Death ⓘ
Apoptosis↑, 1, Fas↑, 1, FasL↑, 1, JNK↑, 1,
Protein Folding & ER Stress ⓘ
HSP90↓, 1,
Autophagy & Lysosomes ⓘ
BNIP3↝, 1, TumAuto↑, 1,
Cell Cycle & Senescence ⓘ
TumCCA↑, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, Hif1a↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
Inflam↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, ChemoSen↑, 1, Dose↝, 1, RadioS↑, 1,
Functional Outcomes ⓘ
cardioP↑, 1, cognitive↑, 1,
Total Targets: 20
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 2, GSH↑, 1, HDL↑, 1, lipid-P↓, 2, MPO↓, 1, ROS?, 1, ROS↓, 5, SOD↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↑, 2, mtDam↓, 1,
Core Metabolism/Glycolysis ⓘ
LDL↓, 1, SIRT1↑, 1,
Cell Death ⓘ
Akt↓, 1, Casp3↓, 1, Casp9↓, 1, Cyt‑c↓, 1, MAPK↓, 1,
Transcription & Epigenetics ⓘ
other↑, 3, other↝, 4, other∅, 1,
Protein Folding & ER Stress ⓘ
HSP70/HSPA5↑, 1, HSPs↑, 1,
DNA Damage & Repair ⓘ
DNAdam↓, 1,
Cell Cycle & Senescence ⓘ
TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
IGF-1↑, 1, IGFBP1↑, 1, PI3K↓, 1, STAT3↓, 1,
Migration ⓘ
MMP2↓, 1, MMP9↓, 2,
Barriers & Transport ⓘ
BBB↑, 2, BBB↝, 1,
Immune & Inflammatory Signaling ⓘ
COX1↓, 1, COX2↓, 2, CRP↓, 1, CXCR4↓, 1, IL10↑, 1, IL17↓, 1, IL18↓, 1, IL1β↓, 2, IL6↓, 3, Inflam↓, 1, NF-kB↓, 1, PGE2↓, 2, TNF-α↓, 3,
Synaptic & Neurotransmission ⓘ
AChE↓, 1, BDNF↑, 1,
Protein Aggregation ⓘ
β-Amyloid↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 2, BioAv↝, 3, Dose↓, 1, Dose⇅, 1, Dose↝, 6, eff↑, 7, eff↝, 1,
Clinical Biomarkers ⓘ
BG↓, 1, BP↓, 1, creat↓, 1, CRP↓, 1, GutMicro↑, 1, IL6↓, 3,
Functional Outcomes ⓘ
AntiAge↑, 1, cardioP↑, 2, cognitive↑, 3, hepatoP↑, 2, memory↑, 1, neuroP↑, 5, OS↑, 1, QoL↑, 1, RenoP↑, 1, Risk↑, 1, toxicity∅, 2,
Total Targets: 73
Scientific Paper Hit Count for: Dose, Dosage
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:75 Cells:% prod#:% Target#:1114 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page